Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Schlom

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|January 19, 2012
Recent advances in therapeutic cancer vaccinesJeffrey Schlom
Journal of the National Cancer Institute|March 8, 2012
Therapeutic cancer vaccines: current status and moving forwardJeffrey Schlom
Cancer Biology & Therapy|August 19, 2010
The MUC1-C oncoprotein as a target in hematologic malignanciesJeffrey Schlom
Expert Review of Vaccines|October 9, 2013
Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid ReesJeffrey Schlom
Experimental Biology and Medicine (Maywood, N.J.)|April 14, 2011
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityCaroline Jochems, Jeffrey Schlom
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Viral vector-based therapeutic cancer vaccinesCecilia Larocca, Jeffrey Schlom
Cancer Immunology, Immunotherapy : CII|August 12, 2008
Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cellsSixun Yang, Jeffrey Schlom
Journal of Biomedicine & Biotechnology|March 20, 2010
Vaccines against human carcinomas: strategies to improve antitumor immune responsesClaudia Palena, Jeffrey Schlom
JAMA|November 13, 2018
Vaccines as an Integral Component of Cancer ImmunotherapyJeffrey Schlom, James L Gulley
Current Oncology Reports|June 14, 2021
Immunology of Lynch SyndromeDanielle M Pastor, Jeffrey Schlom
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
Cancer Biotherapy & Radiopharmaceuticals|January 19, 2012
Recent advances in therapeutic cancer vaccinesJeffrey Schlom
Journal of the National Cancer Institute|March 8, 2012
Therapeutic cancer vaccines: current status and moving forwardJeffrey Schlom
Cancer Biology & Therapy|August 19, 2010
The MUC1-C oncoprotein as a target in hematologic malignanciesJeffrey Schlom
Expert Review of Vaccines|October 9, 2013
Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid ReesJeffrey Schlom
Experimental Biology and Medicine (Maywood, N.J.)|April 14, 2011
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityCaroline Jochems, Jeffrey Schlom
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Viral vector-based therapeutic cancer vaccinesCecilia Larocca, Jeffrey Schlom
Cancer Immunology, Immunotherapy : CII|August 12, 2008
Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cellsSixun Yang, Jeffrey Schlom
Journal of Biomedicine & Biotechnology|March 20, 2010
Vaccines against human carcinomas: strategies to improve antitumor immune responsesClaudia Palena, Jeffrey Schlom
JAMA|November 13, 2018
Vaccines as an Integral Component of Cancer ImmunotherapyJeffrey Schlom, James L Gulley
Current Oncology Reports|June 14, 2021
Immunology of Lynch SyndromeDanielle M Pastor, Jeffrey Schlom
Pageof 33